Physician profile
Mark Hall
NPI 1104899764
$15,337.08
in general payments reported to CMS, 2019-2025
26 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,538 · 2020: $1,292 · 2021: $2,467 · 2022: $1,327 · 2023: $1,172 · 2024: $4,883 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,500 · Food and Beverage: $3,474 · Long Term Medical Supply Or Device Loan: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,500.00 |
| Food and Beverage | $3,473.88 |
| Long Term Medical Supply Or Device Loan | $738.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $3,615.33 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Southern Edge Orthopaedics, INC. | $3,508.52 | 2019-2021 | |
| Stryker Corporation | $2,294.80 | 2019-2025 | Variax, Vitoss, Hoffmann |
| Integra Lifesciences Corporation | $1,117.06 | 2019-2025 | Micromatrix, Integra, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $951.40 | 2019-2025 | Stravix, Collagenase Santyl, Acticoat 4" X 4" |
| Treace Medical Concepts, INC. | $888.11 | 2022-2025 | |
| Depuy Synthes Sales INC. | $523.94 | 2021-2025 | Fibergraft Aeridyan Matrix, Motoband |
| Organogenesis INC. | $478.12 | 2021-2025 | Puraply, Cygnus Dual |
| Djo, LLC | $477.52 | 2019-2025 | Cmf |
| Paratek Pharmaceuticals, INC. | $294.37 | 2023-2024 | Nuzyra |
| Flower Orthopedics Coporation | $198.52 | 2021 | |
| Orthofix Medical, INC. | $184.32 | 2019-2020 | |
| Globus Medical, INC. | $175.83 | 2024 | Harvest, Allocate |
| Abbott Laboratories | $154.35 | 2019-2025 | Esprit |
| Acera Surgical, INC. | $137.53 | 2025 | Restrata Wound Matrix |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $134.81 | 2019-2021 | |
| Ossio INC | $51.55 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $27.70 | 2025 | Exparel |
| Ani Pharmaceuticals, INC. | $20.19 | 2025 | Oxistat |
| Paragon 28, INC. | $18.09 | 2023 | Monkey Rings |
| Boston Scientific Corporation | $16.61 | 2024 | |
| Zimmer Biomet Holdings, INC. | $16.01 | 2021 | |
| Bioventus LLC | $15.83 | 2019 | |
| Cook Medical LLC | $15.55 | 2024 | Cook Celect |
| Kowa Pharmaceuticals America, INC. | $13.89 | 2023 | Seglentis |
| Ossdsign USA Incorporated | $7.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.